...
首页> 外文期刊>European Heart Journal - Case Reports >Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series
【24h】

Unusual intracardiac thrombosis in two patients with coronavirus disease 2019 (COVID-19): case series

机译:2019(Covid-19)的两名患有两种患者的异常心胸血栓形成:案例系列

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background COVID-19 may induce a coagulation dysregulation resulting in a prothrombotic state with a higher risk of arterial and venous thrombosis. This abnormal thrombotic diathesis can lead to pulmonary embolism, stroke, and intracardiac thrombosis. Case summary We present two cases of unusual intracardiac thrombosis in patients hospitalized for COVID-19. In both cases, imaging tests (such as transthoracic echocardiography (TTE), computed tomography scan of the chest, and cardiac magnetic resonance imaging) showed evidence of unusual intracardiac thrombosis with thrombi adherent to regularly contracting walls. Discussion This evidence confirms that COVID-19 induces a hypercoagulable state which can result in intracardiac thrombosis. Therefore, TTE is indicated in all COVID-19 patients for early diagnosis, and prompt anticoagulant therapy is to be considered as a thromboprophylaxis strategy.
机译:背景技术Covid-19可以诱导凝血性失调导致癌细胞,具有较高的动脉和静脉血栓形成的风险。 这种异常的血栓形成素质可导致肺栓塞,中风和心外血栓形成。 案例概要我们在住院治疗Covid-19的患者中展示了两种异常心膜膜血栓形成。 在这两种情况下,成像测试(例如胸部的经脉冲超声心动图(TTE),计算机断层扫描扫描和心脏磁共振成像)显示出与血栓粘附在定期收缩墙壁上不寻常的心膜膜内血栓形成的证据。 讨论证据证实,Covid-19诱导了可能导致心内神经形成血栓形成的超可凝固状态。 因此,在所有Covid-19患者的早期诊断患者中表明TTE,并提示抗凝治疗被认为是血栓催促策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号